CLASS II Device recall · Reported 28 Jan 2015 · FDA Enforcement Report

CD8 (Leu-2a) PE (In vitro diagnostic) recalled

BD Biosciences, Systems & Reagents is recalling CD8 (Leu-2a) PE (In vitro diagnostic), distributed nationwide in the US. The recall was initiated on 19 Dec 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot number 4220622, Expiry 2016-04-30.
Quantity recalled165 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1000-2015
FDA event ID
70107
Recalling firm
BD Biosciences, Systems & Reagents, San Jose, CA
Classification
Class II
Status
Terminated
Recall initiated
19 Dec 2014
FDA classified
20 Jan 2015
Reported
28 Jan 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

19 Dec 2014Recall initiated by company
20 Jan 2015Classified by FDA+32 days
28 Jan 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

One lot of CD8 PE is contaminated with CD4 FITC and may cause an unexpected staining pattern and incorrect patient data.

Product as listed by the FDA

CD8 (Leu-2a) PE (In vitro diagnostic), Catalog number 340046. Hematology: Single color direct immunofluorescence reagent for enumerating percentages of mature human suppressor/cytotoxic (CD8+) lymphocytes in erythrocyte-lysed whole blood or peripheral blood mononuclear cell suspensions.

Where it was distributed

Worldwide distribution. US Nationwide including Puerto Rico, China, Brazil, Japan, Guatemala, India, New Zealand, Australia, Canada, Thailand, Chile and Malaysia.

Nationwide Puerto Rico

Questions about this recall

Is CD8 (Leu-2a) PE (In vitro diagnostic) recalled?

Yes. BD Biosciences, Systems & Reagents recalled CD8 (Leu-2a) PE (In vitro diagnostic) on 19 Dec 2014. The recall is Class II and its status is Terminated. Recall number Z-1000-2015.

Why was it recalled?

One lot of CD8 PE is contaminated with CD4 FITC and may cause an unexpected staining pattern and incorrect patient data.

Which lots are affected?

Lot number 4220622, Expiry 2016-04-30.

Where was it sold?

Worldwide distribution. US Nationwide including Puerto Rico, China, Brazil, Japan, Guatemala, India, New Zealand, Australia, Canada, Thailand, Chile and Malaysia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BD Biosciences, Systems & Reagents

All 9

Other Test Kits & Diagnostics recalls

All 2,656